Geron (GERN) Depreciation & Amortization (CF) (2010 - 2026)

Geron's (GERN) quarterly Depreciation & Amortization (CF) came in at $134000.0 in Q1 2026, up 2.29% year-on-year from $131000.0 in Q1 2025, and up 54.02% quarter-over-quarter from $87000.0 in Q4 2025.

Geron (GERN) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Geron has disclosed Depreciation & Amortization (CF) across 17 years of filings, most recently posting $134000.0 for Q1 2026.

  • Depreciation & Amortization (CF) for Q1 2026 came in at $134000.0, up 2.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $477000.0 (down 15.72% YoY), and the FY2025 annual result was $474000.0, down 13.19% from the prior year.
  • Depreciation & Amortization (CF) came in at $134000.0 for Q1 2026 at Geron, up from $87000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $262000.0 in Q2 2024 to a low of $31000.0 in Q3 2024.
  • The 5-year median for Depreciation & Amortization (CF) is $111000.0 (2024), against an average of $110823.5.
  • Across the five-year window, Depreciation & Amortization (CF) plunged 71.3% in 2024 and soared 312.9% in 2025, its largest moves.
  • Geron's Depreciation & Amortization (CF) stood at $80000.0 in 2022, then jumped by 42.5% to $114000.0 in 2023, then rose by 24.56% to $142000.0 in 2024, then tumbled by 38.73% to $87000.0 in 2025, then jumped by 54.02% to $134000.0 in 2026.
  • The last three Depreciation & Amortization (CF) figures came in at $134000.0 (Q1 2026), $87000.0 (Q4 2025), and $128000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 1,395.22
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -1,330.00
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 55.90 Mn
9 Abivax 91.71 Bn 91.71 Bn - 429,663.65
10 Geron 729,618.77 729,618.77 - 134,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 134,000.00
Mar 31, 2026 134,000.00
Dec 31, 2025 87,000.00
Dec 31, 2025 87,000.00
Sep 30, 2025 128,000.00
Sep 30, 2025 128,000.00
Jun 30, 2025 128,000.00
Jun 30, 2025 128,000.00
Mar 31, 2025 131,000.00
Mar 31, 2025 131,000.00
Dec 31, 2024 142,000.00
Dec 31, 2024 142,000.00
Sep 30, 2024 31,000.00
Sep 30, 2024 31,000.00
Jun 30, 2024 262,000.00
Jun 30, 2024 262,000.00
Mar 31, 2024 111,000.00
Mar 31, 2024 111,000.00
Dec 31, 2023 114,000.00
Dec 31, 2023 114,000.00